US Patent Issued to H. Lundbeck on Sept. 23 for "Agents, uses and methods for the treatment of synucleinopathy" (Danish Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,303, issued on Sept. 23, was assigned to H. Lundbeck A/S (Valby, Denmark).

"Agents, uses and methods for the treatment of synucleinopathy" was invented by Pekka Kallunki (Valby, Denmark), Paul E. G. Kristjansen (Valby, Denmark) and Jeffrey B Stavenhagen (Valby, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to combinational treatment using a monoclonal anti-alpha-synuclein antibody and an additional medicament. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alz...